Trilogy Comparison Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-12

Study Completion Date

2009-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study (Part II) will be to compare the performance of the Trilogy device and a conventional ventilator (participant's current device). Both devices will be set to the participants' current mode and prescription settings.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

NCT00817297

Respiratory Insufficiency Respiratory Failure

COMPLETED NA

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

NCT00817804

Respiratory Insufficiency Respiratory Failure

COMPLETED NA

Ventilator Adapters for Combivent Respimat

NCT01969539

Pulmonary Disease, Chronic Obstructive

TERMINATED PHASE4

Clinical Evaluation of EZVent in Hospitalized Mechanically Ventilated Patients

NCT05399017

Respiratory Failure Respiratory Disease

UNKNOWN NA

Airway Pressure Release Ventilation for Moderate-to-severe Acute Respiratory Distress Syndrome

NCT04156438

Acute Respiratory Distress Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A. Primary Hypothesis and end-point In patients with respiratory insufficiency, when compared to conventional ventilators, the Trilogy device achieves comparable level of gas exchange (measured as partial pressure of CO2 in arterial or venous blood)and SpO2 levels during various modes of ventilation.

B. Secondary Hypothesis and end-points In patients with respiratory insufficiency, when compared to conventional ventilators, the Trilogy device achieves comparable breathing pattern (tidal volume, respiratory rate, minute ventilation), hemodynamics (heart rate), and subjective measures of breathing comfort (measured by modified Borg dyspnea scale).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Trilogy

Trilogy Device

Group Type EXPERIMENTAL

Trilogy

Intervention Type DEVICE

Exposure for one hour on the Trilogy ventilator

Standard of Care

Participants prescribed ventilator

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type DEVICE

Exposure to participants current ventilator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trilogy

Exposure for one hour on the Trilogy ventilator

Intervention Type DEVICE

Standard of Care

Exposure to participants current ventilator

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age \> 21 years of age; \< 85 years of age
2. Able to follow instructions
3. Able to provide informed consent
4. Considered clinically stable, with low flow oxygen requirements less than 15 LPM (or FIO2 less than 60 %) and PEEP no greater than 10 cm H2O.
5. Requiring mechanical ventilation through nasal/facial mask,tracheostomy or endotracheal tube (ET Tube)

Exclusion Criteria

1. Clinically unstable, i.e.,

1. Acute Respiratory Failure
2. Participants with refractory hypotension defined as systolic blood pressure less than 90 mm Hg despite inotropic agents),
3. Uncontrolled cardiac ischemia or arrhythmias,
4. or as otherwise determined inappropriate for the study as determined by the investigator.
2. Patients suffering from metastatic or terminal cancer and patients with do-not-resuscitate orders
3. Pregnancy

Minimum Eligible Age

21 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No